NEW YORK (GenomeWeb News) – The US Food and Drug Administration announced on Monday that it has awarded Harvard University's Wyss Institute for Biologically Inspired Engineering a $5.6 million contract to assess medical countermeasures for treating radiation sickness using Wyss' organs-on-chips technology.

In work carried out as part of the award, researchers at Wyss will develop models of radiation damage in lung, gut, and bone marrow organs-on-chips and then test possible medical countermeasures for radiation sickness on the models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.